Aamaxan Transport Group (OTCPK:AAXT) - Stock Price, News & Analysis

AAXT Stock Overview

Aamaxan Transport Group, Inc. manufactures medical products that are used during hemodialysis therapy. More details

AAXT fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

High level of non-cash earnings

Does not have a meaningful market cap ($2K)

Shares are highly illiquid

Latest financial reports are more than a year old

Aamaxan Transport Group, Inc. Competitors

HyreCar

OTCPK:HYRE.Q

US$6.3k

MingZhu Logistics Holdings

NasdaqCM:YGMZ

US$5.3m

United Express

OTCPK:UNXP

US$43.8m

TuSimple Holdings

OTCPK:TSPH

US$53.5m

Price History & Performance

Summary of all time highs, changes and price drops for Aamaxan Transport Group
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0001
52 Week Low	US$0.0001
Beta	0
11 Month Change	0%
3 Month Change	0%
1 Year Change	n/a
33 Year Change	-99.92%
5 Year Change	-99.96%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	AAXT	US Transportation	US Market
7D	0%	0.09%	0.3%
1Y	n/a	18.3%	31.1%

Return vs Industry: Insufficient data to determine how AAXT performed against the US Transportation industry.

Return vs Market: Insufficient data to determine how AAXT performed against the US Market.

Price Volatility

Is AAXT's price volatile compared to industry and market?
AAXT volatility
AAXT Average Weekly Movement	n/a
Transportation Industry Average Movement	6.5%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.8%
10% least volatile stocks in US Market	3.1%

Stable Share Price: AAXT has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine AAXT's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Chen Zhong	n/a

Aamaxan Transport Group, Inc. manufactures medical products that are used during hemodialysis therapy. The company was founded as Shanghai Medical Technology Co., Ltd. and changed its name to Aamaxan Transport Group, Inc. in April 2008.

Aamaxan Transport Group, Inc. Fundamentals Summary

How do Aamaxan Transport Group's earnings and revenue compare to its market cap?
AAXT fundamental statistics
Market cap	US$1.60k
Earnings (TTM)	US$7.39m
Revenue (TTM)	US$39.13m

0.0x

P/E Ratio

0.0x

P/S Ratio

Is AAXT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AAXT income statement (TTM)
Revenue	US$39.13m
Cost of Revenue	US$24.46m
Gross Profit	US$14.67m
Other Expenses	US$7.28m
Earnings	US$7.39m

Last Reported Earnings

Jun 30, 2008

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did AAXT perform over the long term?

See historical performance and comparison